Global Wearable Heart Monitoring Devices Market Size Study & Forecast, by Product (Electric Pulse-based Product, Optical Technology-based Product), By Devices (Diagnostic & Monitoring Devices, Therapeutic Devices), By Application (Sports & Fitness, Remote

Global Wearable Heart Monitoring Devices Market Size Study & Forecast, by Product (Electric Pulse-based Product, Optical Technology-based Product), By Devices (Diagnostic & Monitoring Devices, Therapeutic Devices), By Application (Sports & Fitness, Remote Patient Monitoring, Home Healthcare), and Regional Analysis, 2023-2030

Global Wearable Heart Monitoring Devices Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Wearable heart monitoring devices are portable electronic devices that are designed to track and continually monitor the activities of the heart. these devices are normally worn on the body, usually on the wrist or chest to monitor and record heart rate, heart rhythm, and other pertinent data. The primary objectives of wearable heart monitoring devices are to identify any irregularities or abnormalities in heart activity and provide users with real-time information about their heart health. Factors such as growing emphasis on personal health and fitness, rising awareness of wearables-based cardiac monitoring, and rapid integration with digital health ecosystems, coupled with the increasing aging population and chronic disease management are driving the market growth worldwide.

Additionally, the increasing prevalence of cardiovascular diseases is directly associated with the demand for wearable heart monitoring devices in the global market. Cardiovascular diseases, such as heart disease, stroke, and arrhythmias, are significant global health concerns. The rising incidence of these conditions has created a greater need for continuous heart monitoring to detect and manage cardiac abnormalities, leading to increased demand for wearable heart monitoring devices. As per the CDC report of October 2022, coronary heart disease is recorded as the most common form of heart disease, and nearly 20.1 million adults aged 20 and over have coronary artery disease (approximately 7.2%). Moreover, according to the American Heart Association, cardiovascular diseases are projected around 17.3 million deaths globally every year. Also, it is estimated that cardiovascular disease cases are likely to rise by about 23.6 million by 2030. Thus, the high burden of coronary artery disease is driving the growth of the market during the estimated period. Furthermore, the growing trend of remote patient monitoring, as well as the increasing technological advancements in wearable devices present various lucrative opportunities over the forecasting years. However, the rising privacy and security concerns regarding wearable devices and the imposition of stringent rules & regulatory policies are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Wearable Heart Monitoring Devices Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising focus on personal health and fitness, along with the presence of major market players and their strategic initiatives in the region. For instance, in March 2022, Biotricity Inc. announce the launch of Biotres- a wireless wearable cardiac monitoring device, which is approved by the FDA. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The rising geriatric population, the presence of a supportive regulatory environment, as well as increasing adoption of remote patient monitoring especially in developing economies are significantly propelling the market demand across the region.

Major market players included in this report are:
Medtronic plc
BioTelemetry, Inc.
Boston Scientific
ZOLL Medical Corporation
Heartbit Holdings Plc.
iRhythm Technologies, Inc.
ACS Diagnostics, Inc.
General Electric Company
Hemodynamics Company LLC
Sonova Holding AG .

Recent Developments in the Market:
In 2021, RhythMedix unveiled the introduction of the RhythmStar- a wearable cardiac monitoring device for arrhythmia detection. The new RhythmStar is a modestly worn gadget that enables long-term remote monitoring without the need for a phone or other communication tools. With the use of the technology, the company's team of licensed experts in the US swiftly examine ECGs and identify cardiac abnormalities, notifying physicians when a potentially serious arrhythmia is found.

Global Wearable Heart Monitoring Devices Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Devices, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Electric Pulse-based Product
Optical Technology-based Product

By Devices:
Diagnostic & Monitoring Devices
Therapeutic Devices

By Application:
Sports & Fitness
Remote Patient Monitoring
Home Healthcare

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa




Companies Mentioned
Medtronic plc
BioTelemetry, Inc.
Boston Scientific
ZOLL Medical Corporation
Heartbit Holdings Plc.
iRhythm Technologies, Inc.
ACS Diagnostics, Inc.
General Electric Company
Hemodynamics Company LLC
Sonova Holding AG

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.